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Abstract
Evidence suggests that genome chromatinization and the posttranslational modification of histones are involved in
the regulation of viral gene expression, including the human cytomegalovirus (HCMV). We performed a ChIP-on-
Chip assay to determine whether histone deacetylases (HDACs) interact with HCMV genomic DNA on a global
level. Surprisingly, we found that HDAC3, but not HDAC2, interacts not only with the major immediate early (MIE)
promoter but also with the entire MIE locus, suggesting a heterogeneous interaction of HDAC3 with HCMV DNA.
The interaction of HDAC3 with the MIE region is related to inhibition of viral replication because HDAC3 inhibitors
enhanced HCMV replication.
Human cytomegalovirus (HCMV) is a ubiquitous virus
and infects a majority of the general population
(50-90%) [1]. The fact that the incidence of cytomegalic
inclusion disease (CID) is intimately related to viral bur-
den suggests that the inhibition of viral production by
the specific repression of viral gene expression will
reduce the occurrence of CID [2]. Understanding the
mechanism of HCMV gene regulation is the pre-requi-
site for developing drugs that interfere with viral replica-
tion by repressing viral gene expression. The HCMV
major immediate early (MIE) gene products, IE1 and
IE2, are among the first de novo-expressed viral proteins
that are required for subsequent viral gene expression
and hence viral replication [3]. IE1 and IE2 mRNAs are
encoded by the major IE locus that spans from 169 to
175 kbp of the viral genome and are produced by alter-
native splicing and differential polyadenylation [4-6]. IE1
and IE2 share the first 85 amino acids [1]. MIE genes
are controlled by a strong promoter/enhancer that con-
tains many regulatory elements [3,7].
Different cellular mechanisms have been found to play
roles in inhibiting viral gene expression, and one of the
most prominent ones is gene silencing through viral
DNA chromatinization (also called chromatin remodel-
ing) [8], a procedure carried out by histone or histone-
related proteins, such as histone acetylase (HAT) and
histone deacetylase (HDAC). Several posttranslational
modifications of histone proteins have been defined to
be involved in chromatin remodeling, including acetyla-
tion by HAT, deacetylation by HDAC, SUMOylation by
SUMO (Small Ubiquitin-like Modifier)-related pathway,
deSUMOylation by SENP (a SUMO-specific protease)
family enzymes, phosphorylation by kinase pathways,
and methylation via methylases [9-13]. Those enzymatic
pathways orchestrate to regulate cellular gene transcrip-
tion and are termed as epigenetic codes [10,13]. Viral
gene transcription requires cellular machinery, which is
probably also regulated by cellular gene regulatory path-
ways. Histones are abundant nuclear proteins and have
been shown to bind with HCMV genomic DNA [14].
Therefore, it was reasonable to propose that chromatin
remodeling of viral DNA takes place in the nucleus,
which speculation was validated when the fact that
HDAC inhibitors can promote cytomegalovirus produc-
tion was also confirmed [15-17].
How HCMV strips off the cellular proteins in order for
the virus to replicate its own DNA is not fully understood.
Recent studies have shown that HCMV and murine CMV
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(or IE3 for MCMV), interact with HDAC1, 2, and 3, and
HDAC inhibitors enhance viral production [17-21], and
dynamic chromatin modification of the MIE promoter
and other viral promoters has been shown. However,
interaction of HDACs with the viral genome has not
been clearly demonstrated [22]. In this study, we per-
formed chromatin immunoprecipitation followed by
microarray on an HCMV DNA chip (ChIP-on-chip)
assay to demonstrate the interaction of HCMV DNA
with HDACs. To our surprise, we found that HDAC3,
but not HDAC2, interacts specifically with the MIE
locus, which suggests a heterogeneous interaction of
HDAC3 with HCMV genomic DNA. In addition, we
f o u n dt h a tt h ei n t e r a c t i o n so fH D A C 3w i t ht h eM I E
locus might relate to the modulation of viral replication
because HDAC3 inhibitors can significantly enhance
viral growth.
The chromatinization of viral DNA after its having
entered the nucleus has been noted not only in latently
infected viruses such as EBV and KSHV (the genomes
of which are tethered to cellular chromosomes) but also
in the lytic infection of HCMV [8,23,24]. On the other
hand, histone proteins have not been found in herpes-
virus virons [25]. Therefore, the chromatinization of
HCMV DNA must be temporary and dynamic. We
wonder 1) whether the HDACs are bound to the
HCMV DNA, and 2) if so, where they interact and
whether the interaction is homogenous or heteroge-
neous. In order to answer these questions, we performed
a ChIP-on-chip assay.
The human foreskin fibroblast cells (HFF) were
infected with HCMV at an MOI of 5. The cells were
fixed at 24 hours postinfection with 1% paraformalde-
hyde. The chromatin immunoprecipitation (ChIP) inputs
were prepared and performed using the commercial kit
(EZ ChIP, Upstate Cell Signal Solutions), according to
the manufacturer’s protocol. The antibodies used for
ChIP assays include anti-HDAC2 (clone 3F3), anti-
HDAC3 (clone 3G6, Upstate USA, Inc.), and normal
IgG (as a negative control).
To generate an HCMV genomic microarray for the
ChIP-on-chip assay, an entire HCMV (Toledo strain)
genomic DNA was subdivided into 593 small DNA frag-
ments and amplified by PCR (primers are listed in Addi-
tional file 1, Table S1). Each PCR fragment was ~500 bp
long with 100 bp overlapping the adjacent fragments.
The PCR products were verified by agarose gels, puri-
fied, quantified, and printed on glass slides, as described
[26]. Each DNA fragment was spotted in triplicate on
each array. The printing quality of the array was con-
trolled by hybridizing the array with a Cyanine 3-dUTP-
labeled random 9-mer, and the slides were scanned
using an Axon 4000A scanner at 532 nm. Figure 1
shows that all 593 HCMV genomic fragments were
printed on the microarray relatively evenly.
Since chromatin immunoprecipitation yields a small
amount of DNA, PCR amplifications are required before
labeling steps. First, precipitated input DNA was ran-
domly primed with a sequence-tagged oligonucleotide
(GTTTCCCAGTCACGATCNNNN NNNNN) to generate
templates with a specific tag at both ends for subsequent
PCR. Then, a specific primer (GTTTCCCAG-TCAC-
GATC) was used to amplify the templates previously gen-
erated. The final amplification consisted of additional PCR
cycles to incorporate aminoallyl-dUTP. The amplified pro-
ducts were then labeled with Alexa Flour 647 or Alexa
Flour 555 and applied to a DNA array of HCMV. The
hybridization was performed according to manufacture’s
instruction (Corning UltraGAPS™).
The slides were scanned using an Axon 4000A scan-
ner. Images were analyzed using GenePix Pro 5.1.
A normalization factor was determined using the ratio
of the median signal intensity of the cy5 and cy3 chan-
nels, and all data sets were normalized to a single med-
ium intensity. A log2 signal intensity ratio for each
fragment was calculated for the ChIP samples that were
pulled down by monoclonal antibody against HDAC3
(or HDAC2 or histone H3) to that by normal IgG. To
correct for the biases in the ChIP procedure, all log
ratios were normalized by subtracting the average log
ratio across the whole array. We considered that a spot
was enriched if the signal intensity from ChIP sample of
anti-HDAC3 was 4-fold greater than the corrected sig-
nal from the IgG ChIP sample.
Figure 1 HCMV array printing quality control.T h ep r i n t i n g
quality was checked by hybridizing the array with a Cyanine
3-dUTP-labeled random 9-mer, and the slides were scanned using
an Axon 4000A scanner at 532 nm. The image showed that all 593
HCMV genomic fragments were printed on the microarray relatively
evenly.
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Page 2 of 5To our surprise, we found that microarray spots cor-
responding to the DNA within the MIE locus interacted
with HDAC3 only, not HDAC2 (Figure 2A, black arrows
and data not shown). The MIE locus is only specific
HDAC3-interacting region found in this study. Some
non-specific hybridization signals were detected, as is
indicated by the grey arrows.
To further confirm the ChIP-on-chip results, we per-
formed a series PCR reactions using primers amplifying
HCMV genomic fragments 113 to 140 (Figure 2,
Additional file 1, Table S1). As shown in Figure 2B, all
HCMV genomic fragments were present in the ChIP
input sample; IgG and HDAC2 did not specifically inter-
act with the HCMV genome; histone H3 interacted with
the entire viral DNA tested; and most importantly,
HDAC3 interacted with fragment 47-53 kb of the
Toledo genome corresponding to the HCMV MIE locus
(Figure 2C, green). To confirm that the anti-HDAC2
antibody is effective for the ChIP assay, we performed
another ChIP assay using anti-HDAC2, -HDAC3
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Figure 2 HDAC3 but not HDAC2 interacts with the MIE locus of HCMV. A. ChIP on Chip assay. HFF cells were infected with the Toledo
strain at MOI 5, and the DNA samples from the infected cells were prepared by using the EZ-ChIP commercial kit. Anti-HDAC2, anti-HDAC3, and
normal IgG (as a negative control) antibodies were used to precipitate the fragmented Protein-DNA complexes. The DNA fragments pulled
down with HDAC3 and IgG antibody were amplified and labeled with Alexa Flour 555 and Alexa Flour 647, respectively and vice-versa. The
labeled DNA was applied to the HCMV genomic Microarray containing the entire HCMV (Toledo strain) genomic DNA divided into 593 small
fragments. The array was scanned at 532 nm (for Cy3) and 635 nm (for Cy5). HDAC3 was detected only in the MIE locus as indicated with black
arrows. The grey arrows indicate no-specific hybridizations. B. PCR verification of the ChIP-on-chip assay. A series of PCR reactions covering the
MIE region was performed on the sample before ChIP (Input) and ChIP samples, as indicated on left. C. HDAC3-interacting map. The ORFs
spanning the MIE locus are shown. HDAC3-interacting region is indicated as green. D. HDAC2/3 ChIP on hTERT promoter. Mrc-5 cells were cross-
linked and ChIP samples were made using the EZ-ChIP commercial kit. Anti-HDAC2 (Anti-2), anti-HDAC3 (Anti-3), and normal IgG (as a negative
control) antibodies were used to precipitate the fragmented Protein-DNA complexes. PCR was performed to detect the precipitated hTERT
promoter DNA using the primers and PCR protocol as reported [27].
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Page 3 of 5antibodies to bind ChIP samples made from uninfected
Mrc-5 cells. The eluted DNA samples were applied for
running PCR against hTERT promoter as reported by
Straat et al. As shown in Figure 2D, HDAC2 bound to
hTERT promoter, which is consistent with the report
[27].
Since HDAC3, like HDAC1 and 2, is one of the major
components of nuclear co-repressors (DNA-remodeling
complexes) inhibiting gene expression, HDAC inhibitors
should be able to counter HDAC3’s repressive effects on
gene expression so that they can promote HCMV viral
replication. To confirm our speculations, we infected
HFF cells with HCMV (at MOIs of 0.1 and 5) in either
the presence or absence of the HDAC inhibitor, Tri-
chostatin A (TSA). Growth-curve analysis showed that
the HDAC inhibitor significantly accelerated viral repli-
cation (Figure 3).
We demonstrated that HDAC3 but not HDAC2
interacts with the HCMV MIE locus. The reason that
HDAC2 was not detected in our assay could be due to
the fact that HDAC2 is known to interact with IE2,
and this binding suppresses the repressive effect of
HDAC2 [20]. At 24 hrs postinfection, the genomic
region around the MIE may need to stay repressed,
which could be accomplished by the action of HDAC3.
This binding of HDAC3 to not only the MIE locus but
also the genes upstream of MIE is intriguing. The
region between the MIE and UL127 has been named as
au n i q u er e g i o nw i t h o u ta n yk n o w nf u n c t i o n .T h i s
region is known to have binding sites for various cellu-
lar repressor proteins that help to repress the tran-
scription of UL127. It is known that the promoter of
UL127 gene is silenced during productive infection in
fibroblasts [28]. The UL126 gene has been reported as
a latency-associated gene [29]. UL124 is a putative
membrane glycoprotein that may be expressed late in
the infection process [30]. It will be interesting to see
how the HDACs bind with those genomic regions at
later times of infection.
HDAC3 has been shown to be a repressor of the
viral MIE promoter [14]. A significant increase in viral
replication in the presence of the HDAC inhibitor
demonstrates that the binding of HDAC3 causes inhi-
bition of viral replication. This inhibition seems to be
more pronounced at a low MOI. Host cells contain
several proteins including gene expression suppressors
that form a defensive arm against viral infection [31].
HCMV has evolved strategies against cellular defense.
We speculate that HCMV infection must reduce
HDAC activity. Both IE1 and IE2 of HCMV were
reported to functionally interact with HDACs [14,
1 8 - 2 0 ] ,a n dI E 1o fM C M Vi sp a r t i c u l a r l ya d e p ta t
reducing HDAC activity [17]. These observations and
our finding of an increase in viral replication in the
presence of TSA further confirm the IE2-mediated
repression of the MIE promoter by the recruitment of
chromatin remodeling factors.
Additional material
Additional file 1: Table S1. PCR primer sequences for HCMV genomic
microarray construction.
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Figure 3 HDAC inhibitors enhance viral replication. HFF cells
were infected with the AD169 strain of HCMV at MOI = 0.1 (panel
A) and MOI = 5 (panel B) both in the presence and absence of TSA
(250 nM). At different times postinfection, virus titer was determined
using the plaque formation assay. Data are expressed as the
average of three independent experiments. As seen in panel A and
B, the production of infectious viral particles with TSA is
approximately 10-fold higher at its maximum than without TSA.
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